Atria Investments’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Atria Investments's ANGO Position: Q2 2026 in Review
Atria Investments reduced its AngioDynamics (ANGO) stake by 1.4% in Q2 2026, selling an estimated $7.1K and leaving 45,208 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #1434.
Atria Investments first reported a position in ANGO in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Atria Investments held 45,208 shares of AngioDynamics worth $588K as of Q2 2026.
- Atria Investments sold 624 AngioDynamics shares in Q2 2026, an estimated $7.1K.
- AngioDynamics made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1434 holding.
- Atria Investments first reported a position in AngioDynamics in Q3 2025 and has held it in 4 quarters since.
- 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.